Public health advocates critical of the market-driven approach of pharmaceutical companies are concerned about the companies
Public health advocates critical of the market-driven approach of pharmaceutical companies are concerned about the companies
Ability to focus on conditions for lucrative customers |
Ability to set drug prices with limited competition |
Ability to avoid focusing on less common conditions without a sufficient customer base
all the above |
The post Public health advocates critical of the market-driven approach of pharmaceutical companies are concerned about the companies appeared first on commompapers.org.